NIH director discusses the $1,000 genome, basic science

02/16/2012 | Medscape (free registration)

Advances in genome sequencing, genomic editing and induced pluripotent stem cells will revolutionize the practice of medicine, NIH Director Francis Collins says in this in-depth interview. For example, iPS cells could be used not only to study a particular patient's disease but also to develop personalized treatments, he says. Basic science supported by the NIH will help scientists develop algorithms to analyze complicated DNA and RNA sequences and translate the information into therapies, he says.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT